Streetwise Reports' Article Archives — Current Month (10)
Recent drill results from Troilus Gold's Quebec project are analyzed in a Red Cloud Securities report.
Cabral Sitting on a Plateau of Gold (07/02/2020)
Bob Moriarty of 321gold discusses the resource calculations at this company's gold project in Brazil and explains why he's an investor.
The president and CEO of Granite Creek Copper outlines prospects for the Stu Copper-Gold project in this conversation with Maurice Jackson of Proven and Probable.
NU Skin Enterprises reported that preliminary Q2/20 revenue exceeded previously forecasted estimates and that the company is experiencing stronger than expected global growth along with accelerated digital adoption.
Analyst: G1 Minimizes the Carnage of Chemotherapy (07/01/2020)
ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA.
Axsome Therapeutics' latest news and clinical outlook are discussed in an H.C. Wainwright & Co. report.
Revive Therapeutics submitted an Investigational New Drug Application to the FDA for a Phase 3 confirmatory study of Bucillamine for treatment in SARS-CoV-2.
Akero Therapeutics shares traded 28% higher and established a new 52-week high after the company reported that it recorded positive histological data across all Efruxifermin dosage groups in its Phase 2a BALANCED Study in NASH patients.
Peter Epstein of Epstein Research interviews Brad Rourke, CEO of Scottie Resources, a 'rising star' working in the prolific Golden Triangle.
In conversation with Maurice Jackson of Proven and Probable, the president and CEO of Riverside Resources describes his company's option agreement with Hochschild Mining and plans to move the Los Cuarentas Gold-Silver Project forward.
|"SYH doubled the strike length of Maverick East to 100m at Moore."|
|"ELY offers shareholders leverage to gold prices through its growing portfolio of long-term gold royalties."|
|"Sampling shows high-grade rhodium potential at PGE's Stillwater West."|
|"MAG is poised to enter production this year."|
|"This looks like a good point to buy TRCH."|